Mineralys Therapeutics, Inc. (MLYS)
29.77
+1.56
(+5.53%)
USD |
NASDAQ |
Feb 06, 16:00
30.31
+0.54
(+1.81%)
After-Hours: 20:00
Mineralys Therapeutics Total Liabilities (Quarterly) : 23.52M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Nektar Therapeutics | 216.26M |
| Lyell Immunopharma, Inc. | 78.84M |
| Arrowhead Pharmaceuticals, Inc. | 1.041B |
| Cidara Therapeutics, Inc. | 96.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 599.95M |
| Shareholders Equity (Quarterly) | 576.43M |
| Current Ratio | 25.50 |